Was  	Was  	 VBD	O
Cipriani  	Cipriani  	 NNP	B-NP
right 	right 	 NN	I-NP
?  	?  	 .	O
Audits  	Audits  	 NN	O
to  	to  	 TO	O
compare  	compare  	 VB	O
discharge  	discharge  	 JJ	B-NP
rates  	rates  	 NNS	I-NP
and  	and  	 CC	O
suicidality  	suicidality  	 NN	B-NP
between  	between  	 IN	O
antidepressant  	antidepressant  	 NNS	B-NP
monotherapies  	monotherapies  	 VBP	O
used  	used  	 VBN	O
in  	in  	 IN	O
a  	a  	 DT	O
British  	British  	 JJ	O
community  	community  	 NN	O
mental  	mental  	 JJ	B-NP
health  	health  	 NN	I-NP
team  	team  	 NN	I-NP
a  	a  	 DT	O
Metanalysis  	Metanalysis  	 NNP	B-NP
by  	by  	 IN	O
Cipriani  	Cipriani  	 NNP	O
recently  	recently  	 RB	O
showed  	showed  	 VBD	O
that  	that  	 DT	O
certain  	certain  	 JJ	O
antidepressants  	antidepressants  	 NN	B-NP
were  	were  	 VBD	O
more  	more  	 RBR	O
effective  	effective  	 JJ	O
and  	and  	 CC	O
better  	better  	 JJR	O
tolerated  	tolerated  	 NN	O
than  	than  	 IN	O
others 	others 	 NNS	O
.  	.  	 .	O
We  	We  	 PRP	O
wished  	wished  	 VBD	O
to  	to  	 TO	O
see  	see  	 VB	O
whether  	whether  	 IN	O
these  	these  	 DT	O
findings  	findings  	 NNS	O
were  	were  	 VBD	O
reflected  	reflected  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
outcomes  	outcomes  	 NN	O
of  	of  	 IN	O
depression  	depression  	 NN	B-NP
treatment  	treatment  	 NN	I-NP
in  	in  	 IN	O
our  	our  	 PRP$	O
Community  	Community  	 NNP	B-NP
Mental  	Mental  	 NNP	I-NP
Health  	Health  	 NNP	I-NP
Team  	Team  	 NNP	I-NP
( 	( 	 -LRB-	O
CMHT 	CMHT 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
we  	we  	 PRP	O
related  	related  	 JJ	O
medication  	medication  	 NN	B-NP
choice  	choice  	 NN	I-NP
and  	and  	 CC	O
dosage  	dosage  	 JJ	B-NP
range  	range  	 NN	I-NP
to  	to  	 TO	O
outcomes  	outcomes  	 VB	O
of  	of  	 IN	O
treatment  	treatment  	 NN	O
as  	as  	 IN	O
reflected  	reflected  	 VBN	O
by  	by  	 IN	O
discharge  	discharge  	 JJ	B-NP
rates  	rates  	 NNS	I-NP
and  	and  	 CC	O
suicidality.  	suicidality.  	 CD	B-NP
in  	in  	 IN	O
this  	this  	 DT	O
paper  	paper  	 NN	O
we  	we  	 PRP	O
emphasize  	emphasize  	 VB	O
the  	the  	 DT	O
relationship  	relationship  	 NN	B-NP
of  	of  	 IN	O
Dose  	Dose  	 NNP	O
Range  	Range  	 NNP	O
to  	to  	 TO	O
outcome 	outcome 	 NN	O
.  	.  	 .	O
Our  	Our  	 PRP$	O
results  	results  	 NNS	O
are  	are  	 VBP	O
in  	in  	 IN	O
accord  	accord  	 NN	B-NP
with  	with  	 IN	O
those  	those  	 DT	O
of  	of  	 IN	O
Cipriani 	Cipriani 	 NNP	O
.  	.  	 .	O
We  	We  	 PRP	O
note  	note  	 VBP	O
that  	that  	 IN	O
Prescription  	Prescription  	 NNP	B-NP
of  	of  	 IN	O
' 	' 	 ''	O
the  	the  	 DT	O
four 	four 	 CD	O
'  	'  	 ''	O
was  	was  	 VBD	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
a  	a  	 DT	O
greater  	greater  	 JJR	O
percentage  	percentage  	 NN	O
of  	of  	 IN	O
patients  	patients  	 NNS	O
discharged  	discharged  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
clinic  	clinic  	 NN	O
than  	than  	 IN	O
' 	' 	 ''	O
the  	the  	 DT	O
others 	others 	 NNS	O
' 	' 	 POS	O
.  	.  	 .	O
Sertraline  	Sertraline  	 NNP	B-NP
was  	was  	 VBD	O
the  	the  	 DT	O
antidepressant  	antidepressant  	 JJ	O
most  	most  	 RBS	O
likely  	likely  	 JJ	O
to  	to  	 TO	O
reduce  	reduce  	 VB	O
suicidality  	suicidality  	 VBN	O
in  	in  	 IN	O
our  	our  	 PRP$	O
sample 	sample 	 NN	O
.  	.  	 .	O
For  	For  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
unipolar  	unipolar  	 JJ	B-NP
depression 	depression 	 NN	I-NP
,  	,  	 ,	O
discharge  	discharge  	 JJ	B-NP
rates  	rates  	 NNS	I-NP
were  	were  	 VBD	O
higher  	higher  	 JJR	O
when  	when  	 WRB	O
they  	they  	 PRP	O
were  	were  	 VBD	O
prescribed  	prescribed  	 VBN	O
one  	one  	 CD	O
of  	of  	 IN	O
the  	the  	 DT	O
four  	four  	 CD	O
medications  	medications  	 NNS	O
indicated  	indicated  	 VBD	O
by  	by  	 IN	O
Cipriani  	Cipriani  	 NNP	O
and  	and  	 CC	O
highest  	highest  	 JJS	O
when  	when  	 WRB	O
prescribed  	prescribed  	 JJ	O
escitalopram 	escitalopram 	 NN	B-NP
.  	.  	 .	O
For  	For  	 IN	O
patients  	patients  	 NNS	O
who  	who  	 WP	O
also  	also  	 RB	O
had  	had  	 VBD	O
other  	other  	 JJ	O
indications 	indications 	 NNS	O
,  	,  	 ,	O
discharge  	discharge  	 JJ	B-NP
rates  	rates  	 NNS	I-NP
were  	were  	 VBD	O
higher  	higher  	 JJR	O
for  	for  	 IN	O
the  	the  	 DT	O
group  	group  	 NN	O
other  	other  	 JJ	O
than  	than  	 IN	O
the  	the  	 DT	O
four  	four  	 CD	O
antidepressants  	antidepressants  	 NNS	B-NP
identified  	identified  	 VBN	O
by  	by  	 IN	O
Cipriani  	Cipriani  	 NNP	O
and  	and  	 CC	O
highest  	highest  	 JJS	O
for  	for  	 IN	O
fluoxetine 	fluoxetine 	 NN	B-NP
.  	.  	 .	O
Regarding  	Regarding  	 VBG	B-NP
Dose  	Dose  	 NNP	I-NP
Ranges 	Ranges 	 NNP	I-NP
,  	,  	 ,	O
we  	we  	 PRP	O
note  	note  	 VBP	O
that  	that  	 IN	O
wheras  	wheras  	 JJ	O
many  	many  	 JJ	O
patients  	patients  	 NNS	O
had  	had  	 VBD	O
their  	their  	 PRP$	O
dosage  	dosage  	 JJ	O
titrated  	titrated  	 JJ	O
upwards  	upwards  	 NN	O
from  	from  	 IN	O
the  	the  	 DT	O
starting  	starting  	 VBG	B-NP
dose 	dose 	 NN	I-NP
,  	,  	 ,	O
most  	most  	 JJS	O
did  	did  	 VBD	O
not  	not  	 RB	O
have  	have  	 VB	O
the  	the  	 DT	O
dosage  	dosage  	 JJ	O
titrated  	titrated  	 NN	O
to  	to  	 TO	O
the  	the  	 DT	O
highest  	highest  	 JJS	O
dose  	dose  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
relevant  	relevant  	 JJ	O
medication.  	medication.  	 NN	O
it  	it  	 PRP	O
does  	does  	 VBZ	O
appear  	appear  	 VB	O
that  	that  	 IN	O
the  	the  	 DT	O
antidepressants  	antidepressants  	 NN	B-NP
identified  	identified  	 VBN	O
by  	by  	 IN	O
Cipriani  	Cipriani  	 NNP	O
are  	are  	 VBP	O
effective  	effective  	 JJ	O
compared  	compared  	 VBN	O
with  	with  	 IN	O
other  	other  	 JJ	O
monotherapies 	monotherapies 	 NN	B-NP
.  	.  	 .	O
Medication  	Medication  	 NN	B-NP
doses  	doses  	 NNS	I-NP
need  	need  	 VBP	O
to  	to  	 TO	O
be  	be  	 VB	O
optimised  	optimised  	 VBN	O
in  	in  	 IN	O
order  	order  	 NN	O
to  	to  	 TO	O
achieve  	achieve  	 VB	O
optimal  	optimal  	 JJ	B-NP
treatment  	treatment  	 NN	I-NP
in  	in  	 IN	O
Depression 	Depression 	 NNP	O
.  	.  	 .	O
Our  	Our  	 PRP$	O
results  	results  	 NNS	O
suggest  	suggest  	 VBP	O
that  	that  	 IN	O
co-morbid  	co-morbid  	 JJ	O
undiagnosed  	undiagnosed  	 JJ	O
other  	other  	 JJ	O
mental  	mental  	 JJ	B-NP
illness  	illness  	 NN	I-NP
may  	may  	 MD	O
often  	often  	 RB	O
be  	be  	 VB	O
a  	a  	 DT	O
cause  	cause  	 NN	O
of  	of  	 IN	O
' 	' 	 POS	O
resistant  	resistant  	 JJ	O
depression 	depression 	 NN	O
' 	' 	 POS	O
.  	.  	 .	O
We  	We  	 PRP	O
recommend  	recommend  	 VBP	O
that  	that  	 IN	O
all  	all  	 DT	O
CMHTs  	CMHTs  	 NN	B-NP
should  	should  	 MD	O
carry  	carry  	 VB	O
out  	out  	 RP	O
audits  	audits  	 NN	O
of  	of  	 IN	O
their  	their  	 PRP$	O
prescribing  	prescribing  	 JJ	O
practice  	practice  	 NN	O
in  	in  	 IN	O
order  	order  	 NN	O
to  	to  	 TO	O
optimise  	optimise  	 VB	O
treatment  	treatment  	 NN	B-NP
outcomes 	outcomes 	 NNS	I-NP
.  	.  	 .	O
